José Luís Passos‐Coelho

FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer

Mafalda Oliveira, Cristina Saura, Paolo Nucíforo et al. · Annals of Oncology · 2019 · 149 citations · Full text

Breast Oncology, Phase Ii Trial, Medicine +6

The aggressiveness of cancer care in the last three months of life: a retrospective single centre analysis

Sofía Braga, Ana Miranda, Rute Fonseca et al. · Psycho-Oncology · 2007 · 112 citations

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO

Xavier Pivot, Andreas Schneeweiß, Shailendra Verma et al. · European Journal of Cancer · 2011 · 108 citations

Metastatic Breast Cancer, Breast Oncology, Elderly Patients +8

Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.

Tai‐Lin Chen, José Luís Passos‐Coelho, D A Noe et al. · PubMed · 1995 · 103 citations

Nonlinear Pharmacokinetics, Metastatic Breast Cancer, Pharmacokinetic Modeling +14

Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)

Robert E. Coleman, Michelle Collinson, Walter M. Gregory et al. · Journal of bone oncology · 2018 · 100 citations · Full text